Actively Recruiting

Age: 50Years +
All Genders
NCT05206981

Device Global Registry for the IlluminOss Bone Stabilization System

Led by IlluminOss Medical, Inc. · Updated on 2026-04-17

300

Participants Needed

16

Research Sites

285 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.

CONDITIONS

Official Title

Device Global Registry for the IlluminOss Bone Stabilization System

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient has been deemed a candidate for the IlluminOss device
  • Patient is male or non-pregnant female
  • Patient is willing and able to comply with the postoperative scheduled clinical and radiographic evaluations
  • Patient is willing and able to give informed consent if required
  • Traumatic patient is over the age of 50
  • IlluminOss procedure is the initial procedure to treat the traumatic injury
Not Eligible

You will not qualify if you...

  • Active or incompletely treated infection at the device implant site
  • Allergy to any implant materials or dental glue
  • Intramedullary canal smaller than delivery sheath diameter at fracture site
  • Distant infections that may spread to implant site
  • Open fractures with severe contamination
  • Delivery sheath unable to cross fracture site after proper reduction and realignment
  • Skeletally immature patients (EU only)
  • Uncooperative or neurologically impaired patients unable to follow directions (EU only)
  • Vascular insufficiency (EU only)
  • Extremely comminuted fractures with probable insufficient balloon holding power (EU only)
  • Patients under age 50 with acute humerus fractures (EU only)
  • Metabolic disorders impairing bone formation (EU only)
  • Osteomalacia (EU only)
  • Muscular atrophy or neuromuscular disease (EU only)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 16 locations

1

Gulf Orthopedics

Mobile, Alabama, United States, 36604

Completed

2

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

Actively Recruiting

3

Presbyterian St Luke's Medical Ctr

Denver, Colorado, United States, 80218

Actively Recruiting

4

University of Miami Hospital

Miami, Florida, United States, 33136

Actively Recruiting

5

Weston Outpatient Surgical Center

Weston, Florida, United States, 33326

Actively Recruiting

6

Parkview Health

Fort Wayne, Indiana, United States, 46845

Withdrawn

7

Jacobi Medical Center

The Bronx, New York, United States, 10461

Actively Recruiting

8

Mission Hospital

Asheville, North Carolina, United States, 28801

Withdrawn

9

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States, 27157

Actively Recruiting

10

Temple University Hospital

Philadelphia, Pennsylvania, United States, 19140

Actively Recruiting

11

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15232

Actively Recruiting

12

Ortho Rhode Island

Wakefield, Rhode Island, United States, 02879

Actively Recruiting

13

Memorial Hermann Hospital

Katy, Texas, United States, 77494

Actively Recruiting

14

St Vinzenz Hospital

Cologne, Germany

Withdrawn

15

Johannes Wesling Hospital Minden

Minden, Germany

Completed

16

Petrus Hospital

Wuppertal, Germany

Completed

Loading map...

Research Team

L

Lisa Holt, PhD

CONTACT

C

Caitlin Smith, MPH

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here